Core Laboratories Stock Valuation

CLB
 Stock
  

USD 21.50  0.18  0.83%   

Do you wonder what the value of Core Laboratories is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Core Laboratories, is its stock price multiplied by the total number of shares outstanding, calculating Core Laboratories' enterprise value requires a different approach. It uses Core Laboratories' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
The current year Free Cash Flow is expected to grow to about 24 M. The current year Enterprise Value is expected to grow to about 1.3 B.
Core Laboratories shows a prevailing Real Value of $23.14 per share. The current price of the firm is $21.5. At this time, the firm appears to be undervalued. Our model approximates the value of Core Laboratories from analyzing the firm fundamentals such as Current Valuation of 1.19 B, profit margin of 0.0316 %, and Return On Equity of 9.19 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor taking in undervalued instruments and trading overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
  
Core Laboratories Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Core Laboratories's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Core Laboratories Most Recent Valuation Data

Dividend Share
0.04
Beta
2.63
change Receivables
-13.5 M
Fiscal Year End
December
property Plant And Equipment Net
172.3 M
Enterprise Value
1.2 B
Undervalued
Today 21.50
Please note that Core Laboratories' price fluctuation is not too volatile at this time. Calculation of the real value of Core Laboratories is based on 3 months time horizon. Increasing Core Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Core Laboratories NV is useful when determining the fair value of the Core Laboratories stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Core Laboratories. Since Core Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Core Laboratories Stock. However, Core Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
23.14
Real Value
27.45
Upside
Estimating the potential upside or downside of Core Laboratories NV helps investors to forecast how Core Laboratories stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Core Laboratories more accurately as focusing exclusively on Core Laboratories' fundamentals will not take into account other important factors:
Earnings
Estimates (5)
LowProjected EPSHigh
0.550.660.70
Details
Hype
Prediction
LowEstimated ValueHigh
17.3021.6125.92
Details
Potential
Annual Dividend
LowIncome Per ShareHigh
0.0265240.0266670.026809
Details
6 Analysts
Consensus
LowTarget PriceHigh
17.5026.4236.00
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Core Laboratories' intrinsic value based on its ongoing forecasts of Core Laboratories' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Core Laboratories' closest peers. When choosing an evaluation method for Core Laboratories, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Core Laboratories Valuation Drivers Correlation

Many accounts on the financial statements of Core Laboratories are highly interrelated and sometimes correlated. Consequently, when conducting Core Laboratories's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Core Laboratories
Click cells to compare fundamentals

Core Laboratories Valuation Trend

Knowing Core Laboratories' actual value is paramount for traders to make sound investment determinations. Core Laboratories' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Core Laboratories' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Core Laboratories' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Core Laboratories Market Cap

Core Laboratories NV is number one stock in market capitalization category among related companies. Market capitalization of Energy industry is currently estimated at about 123.31 Billion. Core Laboratories maintains roughly 964.99 Million in market capitalization contributing less than 1% to equities under Energy industry.
Capitalization  Revenue  Valuation  Total debt  Workforce

Core Laboratories Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Core Laboratories's current stock value. Our valuation model uses many indicators to compare Core Laboratories value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Core Laboratories competition to find correlations between indicators driving Core Laboratories's intrinsic value. More Info.
Core Laboratories NV is number one stock in annual yield category among related companies. It is number one stock in five year return category among related companies reporting about  1,330  of Five Year Return per Annual Yield. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Core Laboratories by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Core Laboratories' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Core Laboratories' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Core Laboratories' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Core Laboratories and how it compares across the competition.

About Core Laboratories Valuation

The stock valuation mechanism determines the current worth of Core Laboratories NV on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Core Laboratories NV. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Core Laboratories based exclusively on its fundamental and basic technical indicators. By analyzing Core Laboratories's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Core Laboratories's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Core Laboratories. We calculate exposure to Core Laboratories's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Core Laboratories's related companies.
Fiscal Year End
December
Industry
Oil & Gas Equipment & Services
Concentration
Oil & Gas Equipment & Services
Full Time Employees
3.6 K
Service Category
Energy Equipment & Services
Last ReportedProjected for 2022
Gross Profit102.4 M157.1 M
Profit Margin 0.042  0.0431 
Core Laboratories' stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Core Laboratories' value is low or high relative to the company's performance and growth projections. Determining the market value of Core Laboratories can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of Core Laboratories represents a small ownership stake in the entity. As a stockholder of Core Laboratories, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

Core Laboratories Dividends Analysis For Valuation

Core Laboratories Dividend Yield is projected to increase slightly based on the last few years of reporting. The past year's Dividend Yield was at 0.002. The current year Dividends per Basic Common Share is expected to grow to 0.0411, whereas Payment of Dividends and Other Cash Distributions is forecasted to decline to (2 M). . Core Laboratories Accumulated Retained Earnings Deficit are projected to decrease significantly based on the last few years of reporting. The past year's Accumulated Retained Earnings Deficit were at 68.35 Million. The current year Earning Before Interest and Taxes EBIT is expected to grow to about 45.9 M, whereas Price to Earnings Ratio are forecasted to decline to 41.81.
Last ReportedProjected for 2022
Payment of Dividends and Other Cash Distributions-1.8 M-2 M
Dividend Yield 0.002  0.002053 
Dividends per Basic Common Share 0.04  0.0411 
There are various types of dividends Core Laboratories can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Core Laboratories shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Core Laboratories NV directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Core Laboratories pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Core Laboratories by the value of the dividends paid out.

Core Laboratories Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Core Laboratories does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quarterly Earnings Growth Y O Y7.474

Core Laboratories Current Valuation Indicators

Valuation refers to the process of determining the present value of Core Laboratories NV and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Core Laboratories we look at many different elements of the entity such as Core Laboratories's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Core Laboratories' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Core Laboratories' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Core Laboratories, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Core Laboratories' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Core Laboratories' worth.
Continue to Trending Equities. You can also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for analysis

When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core Laboratories will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
7.47
Market Capitalization
965 M
Quarterly Revenue Growth YOY
0.068
Return On Assets
0.044
Return On Equity
9.19
The market value of Core Laboratories is measured differently than its book value, which is the value of Core Laboratories that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Core Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.